Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Sunday, July 29, 2012

10 to 12 million Pakistanis infected with hepatitis B and C

KARACHI: Early detection and effective treatment are the keys to combat viral hepatitis. A research conducted at Aga Khan University (AKU) suggests that out of nearly 70 percent of patients suffering from Hepatitis C, younger patients with hepatitis C genotype 3 infections have the best chance of a cure provided they are diagnosed early and treated effectively.

The data was shared by doctors in an event organised at AKU in collaboration with Pakistan Society for the Study of liver diseases, to mark World Hepatitis Day. An AKU statement said that many people are chronic carriers of hepatitis B and C in Pakistan, show no symptoms, and yet develop severe liver problems later in life. Dr Saeed Hamid, Chair, Department of Medicine, AKU added that according to recent national surveys, it is estimated that 10 to 12 million Pakistanis are infected with hepatitis B and C. “Hepatitis can affect anyone; therefore know it, confront it and get tested,” urged Dr Hamid. Dr Wasim Jafri, Associate Dean, Department of Continuing Professional Education, AKU elaborated that Hepatitis B could be easily diagnosed and effectively controlled through

Read more...

No comments:

Post a Comment